Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

P3 Health Partners stock price, quote, forecast and news

PIII
US7444131053

Price

0.46
Today +/-
-0.01
Today %
-3.42 %
P

P3 Health Partners stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the P3 Health Partners stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the P3 Health Partners stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the P3 Health Partners stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze P3 Health Partners's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

P3 Health Partners Stock Price History

DateP3 Health Partners Price
9/6/20240.46 undefined
9/5/20240.48 undefined
9/4/20240.46 undefined
9/3/20240.46 undefined
8/30/20240.50 undefined
8/29/20240.50 undefined
8/28/20240.47 undefined
8/27/20240.50 undefined
8/26/20240.51 undefined
8/23/20240.50 undefined
8/22/20240.49 undefined
8/21/20240.52 undefined
8/20/20240.53 undefined
8/19/20240.56 undefined
8/16/20240.60 undefined
8/15/20240.59 undefined
8/14/20240.59 undefined
8/13/20240.60 undefined
8/12/20240.55 undefined

P3 Health Partners Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into P3 Health Partners, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by P3 Health Partners from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects P3 Health Partners’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of P3 Health Partners. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into P3 Health Partners’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing P3 Health Partners’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on P3 Health Partners’s growth potential.

P3 Health Partners Revenue, EBIT and net profit per share

DateP3 Health Partners RevenueP3 Health Partners EBITP3 Health Partners Net Income
2026e2.15 B undefined0 undefined47.43 M undefined
2025e1.78 B undefined-83.7 M undefined-76.62 M undefined
2024e1.56 B undefined-93.94 M undefined-104.9 M undefined
20231.27 B undefined-167.93 M undefined-57.77 M undefined
20221.05 B undefined-245.9 M undefined-270.1 M undefined
2021637.4 M undefined-187.9 M undefined-156.5 M undefined
2020485.5 M undefined-35.1 M undefined-41.1 M undefined
2019145.9 M undefined-39.5 M undefined-35 M undefined
201887.7 M undefined-49.7 M undefined-43.8 M undefined

P3 Health Partners Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2018201920202021202220232024e2025e2026e
0.090.150.490.641.051.271.561.782.15
-66.67234.4831.3464.6820.6922.8314.1520.90
-4.602.76--3.45-0.672.45---
-440-22-731000
-49-39-35-187-245-167-93-830
-56.32-26.90-7.22-29.36-23.36-13.19-5.98-4.68-
-43-35-41-156-270-57-104-7647
--18.6017.14280.4973.08-78.8982.46-26.92-161.84
41.641.641.641.641.694.89000
---------
Details

Keystats

ⓘ

Revenue and Growth

The P3 Health Partners Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the P3 Health Partners is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20192020202120222023
         
32.636.3140.517.536.32
1839.151.372.9118.5
0.40.20.86.72.97
00000
1.38.87.43.58.23
52.384.4200100.6166.02
8.810.915.18.88.69
00000
3.73.83.600
00835.8751.1666.73
001.3100
0001619.53
0.010.022.160.780.69
0.070.12.360.880.86
         
89.797.2000.03
00312.9315.4509.44
-84.2-125.1-39.4-309.5-367.34
00000
00000
5.5-27.9273.55.9142.13
28.582.5140.1174.7218.96
24.58.15566.980.41
00000
003.600
1.60.1000
54.690.7198.7241.6299.37
1545.48094.4108.32
00000
4.41021.217.819.61
19.455.4101.2112.2127.93
74146.1299.9353.8427.31
79.5118.2573.4359.7569.44
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of P3 Health Partners provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand P3 Health Partners's financial health and stability.

Assets

P3 Health Partners's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that P3 Health Partners must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of P3 Health Partners after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into P3 Health Partners's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20182019202020212022
-49-42-45-204-1,561
000887
00000
56327535
0.020.01-0.010.051.33
00045
00000
-29-28-24-66-126
-3-1-2-3-2
-4-3-3-56-7
-1-20-52-5
00000
01342811
336201950
33633422311
-----
00000
0316100-122
-32.55-29.74-27.53-69.88-128.25
00000

P3 Health Partners stock margins

The P3 Health Partners margin analysis displays the gross margin, EBIT margin, as well as the profit margin of P3 Health Partners. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for P3 Health Partners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the P3 Health Partners's sales revenue. A higher gross margin percentage indicates that the P3 Health Partners retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the P3 Health Partners's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the P3 Health Partners's total revenue generated. When comparing the revenue margin year over year, investors can gauge the P3 Health Partners's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the P3 Health Partners. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the P3 Health Partners's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

P3 Health Partners Margin History

P3 Health Partners Gross marginP3 Health Partners Profit marginP3 Health Partners EBIT marginP3 Health Partners Profit margin
2026e2.5 %0 %2.21 %
2025e2.5 %-4.72 %-4.32 %
2024e2.5 %-6.04 %-6.75 %
20232.5 %-13.26 %-4.56 %
2022-0.74 %-23.43 %-25.74 %
2021-3.45 %-29.48 %-24.55 %
20202.5 %-7.23 %-8.47 %
20193.08 %-27.07 %-23.99 %
2018-5.47 %-56.67 %-49.94 %

P3 Health Partners Stock Sales Revenue, EBIT, Earnings per Share

The P3 Health Partners earnings per share therefore indicates how much revenue P3 Health Partners has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue P3 Health Partners earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates P3 Health Partners's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of P3 Health Partners’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating P3 Health Partners's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

P3 Health Partners Revenue, EBIT and net profit per share

DateP3 Health Partners Sales per ShareP3 Health Partners EBIT per shareP3 Health Partners Earnings per Share
2026e6 undefined0 undefined0.13 undefined
2025e4.96 undefined0 undefined-0.21 undefined
2024e4.35 undefined0 undefined-0.29 undefined
202313.35 undefined-1.77 undefined-0.61 undefined
202225.23 undefined-5.91 undefined-6.49 undefined
202115.32 undefined-4.52 undefined-3.76 undefined
202011.67 undefined-0.84 undefined-0.99 undefined
20193.51 undefined-0.95 undefined-0.84 undefined
20182.11 undefined-1.19 undefined-1.05 undefined

P3 Health Partners business model

P3 Health Partners is one of the most popular companies on Eulerpool.com.

P3 Health Partners Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

P3 Health Partners historical P/E ratio, EBIT, and P/S ratio.

P3 Health Partners shares outstanding

The number of shares was P3 Health Partners in 2023 — This indicates how many shares 94.889 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue P3 Health Partners earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates P3 Health Partners's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of P3 Health Partners’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating P3 Health Partners's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

P3 Health Partners Stock splits

In P3 Health Partners's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for P3 Health Partners.

P3 Health Partners latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.05 -0.09  (-76.47 %)2024 Q2
3/31/2024-0.11 -0.16  (-47.06 %)2024 Q1
12/31/2023-0.11 -0.22  (-96.08 %)2023 Q4
9/30/2023-0.22 -0.12  (46.52 %)2023 Q3
6/30/2023-0.13 -0.09  (32.13 %)2023 Q2
3/31/2023-0.69 -0.22  (68.05 %)2023 Q1
12/31/2022-0.93 -2.26  (-143.48 %)2022 Q4
9/30/2022-0.47 -0.27  (42.87 %)2022 Q3
6/30/2022-0.16 -0.21  (-28.68 %)2022 Q2
3/31/2022-0.13 -0.25  (-98.73 %)2022 Q1
1
2

P3 Health Partners list of shareholders

%
Name
Stocks
Change
Date
3.76597 % Chicago Pacific Founders UGP LLC13,471,63704/21/2023
2.75047 % Leavitt Equity Partners II LP9,838,9979,838,9974/6/2023
1.51917 % Columbia Wanger Asset Management, LLC5,434,3721,63012/31/2023
1.05804 % Janus Henderson Investors3,784,824012/31/2023
0.65236 % BlackRock Institutional Trust Company, N.A.2,333,635162,43212/31/2023
0.63080 % Bacchus (Amir)2,256,491287,1181/9/2024
0.54781 % Alyeska Investment Group, L.P.1,959,628012/31/2023
0.44963 % Abdou (Sherif)1,608,422483,8681/9/2024
0.43628 % The Vanguard Group, Inc.1,560,655-1,016,60512/31/2023
0.30085 % Wasson (Gregory D)1,076,209216,56110/23/2023
1
2
3
4
5
...
10

P3 Health Partners Executives and Management Board

Dr. Sherif Abdou62
P3 Health Partners Chief Executive Officer, Co-Founder, Director (since 2017)
Compensation 7.1 M
Dr. Amir Bacchus59
P3 Health Partners Co-Founder, Chief Medical Officer, Director (since 2017)
Compensation 4.3 M
Mr. Atul Kavthekar55
P3 Health Partners Chief Financial Officer, Principal Accounting Officer
Compensation 1.36 M
Mr. Mark Thierer63
P3 Health Partners Independent Chairman of the Board
Compensation 1.26 M
Mr. Jeffrey Park51
P3 Health Partners Independent Director
Compensation 339,762
1
2
3

Most common questions regarding P3 Health Partners

What is the P/E ratio of P3 Health Partners 2024?

The P3 Health Partners P/E ratio is -0.42.

What is the P/S ratio of P3 Health Partners 2024?

The P3 Health Partners P/S ratio is 0.03.

What is the AlleAktien quality score of P3 Health Partners?

The AlleAktien quality score for P3 Health Partners is 4/10.

What is the revenue of P3 Health Partners 2024?

The expected P3 Health Partners revenue is 1.56 B USD.

How high is the profit of P3 Health Partners 2024?

The expected P3 Health Partners profit is -104.9 M USD.

What is the business model of P3 Health Partners

No history available for P3 Health Partners.

What is the P3 Health Partners dividend?

P3 Health Partners pays a dividend of 0 USD distributed over payouts per year.

How often does P3 Health Partners pay dividends?

The dividend cannot currently be calculated for P3 Health Partners or the company does not pay out a dividend.

What is the P3 Health Partners ISIN?

The ISIN of P3 Health Partners is US7444131053.

What is the P3 Health Partners ticker?

The ticker of P3 Health Partners is PIII.

How much dividend does P3 Health Partners pay?

Over the past 12 months, P3 Health Partners paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, P3 Health Partners is expected to pay a dividend of 0 USD.

What is the dividend yield of P3 Health Partners?

The current dividend yield of P3 Health Partners is .

When does P3 Health Partners pay dividends?

P3 Health Partners pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of P3 Health Partners?

P3 Health Partners paid dividends every year for the past 0 years.

What is the dividend of P3 Health Partners?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is P3 Health Partners located?

P3 Health Partners is assigned to the 'Health' sector.

Wann musste ich die Aktien von P3 Health Partners kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of P3 Health Partners from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did P3 Health Partners pay the last dividend?

The last dividend was paid out on 9/10/2024.

What was the dividend of P3 Health Partners in the year 2023?

In the year 2023, P3 Health Partners distributed 0 USD as dividends.

In which currency does P3 Health Partners pay out the dividend?

The dividends of P3 Health Partners are distributed in USD.

All fundamentals about P3 Health Partners

Our stock analysis for P3 Health Partners Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of P3 Health Partners Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.